nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—saliva—attention deficit hyperactivity disorder	0.0433	0.117	CbGeAlD
Disopyramide—KCND2—forebrain—attention deficit hyperactivity disorder	0.0216	0.0582	CbGeAlD
Disopyramide—KCND3—forebrain—attention deficit hyperactivity disorder	0.0188	0.0508	CbGeAlD
Disopyramide—KCND2—cardiovascular system—attention deficit hyperactivity disorder	0.0183	0.0492	CbGeAlD
Disopyramide—KCND3—cardiovascular system—attention deficit hyperactivity disorder	0.0159	0.0429	CbGeAlD
Disopyramide—KCND2—midbrain—attention deficit hyperactivity disorder	0.0143	0.0384	CbGeAlD
Disopyramide—KCND3—midbrain—attention deficit hyperactivity disorder	0.0124	0.0335	CbGeAlD
Disopyramide—KCND2—nervous system—attention deficit hyperactivity disorder	0.0117	0.0316	CbGeAlD
Disopyramide—KCND2—central nervous system—attention deficit hyperactivity disorder	0.0113	0.0304	CbGeAlD
Disopyramide—KCND2—cerebellum—attention deficit hyperactivity disorder	0.011	0.0297	CbGeAlD
Disopyramide—KCND3—nervous system—attention deficit hyperactivity disorder	0.0102	0.0276	CbGeAlD
Disopyramide—KCND3—central nervous system—attention deficit hyperactivity disorder	0.00984	0.0265	CbGeAlD
Disopyramide—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00962	0.0259	CbGeAlD
Disopyramide—KCND3—cerebellum—attention deficit hyperactivity disorder	0.00961	0.0259	CbGeAlD
Disopyramide—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.00955	0.0258	CbGeAlD
Disopyramide—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00945	0.0255	CbGeAlD
Disopyramide—KCND2—brain—attention deficit hyperactivity disorder	0.00896	0.0242	CbGeAlD
Disopyramide—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00876	0.0236	CbGeAlD
Disopyramide—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00813	0.0219	CbGeAlD
Disopyramide—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00784	0.0211	CbGeAlD
Disopyramide—KCND3—brain—attention deficit hyperactivity disorder	0.00781	0.0211	CbGeAlD
Disopyramide—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0074	0.02	CbGeAlD
Disopyramide—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00613	0.0165	CbGeAlD
Disopyramide—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00591	0.0159	CbGeAlD
Disopyramide—ORM1—nervous system—attention deficit hyperactivity disorder	0.0056	0.0151	CbGeAlD
Disopyramide—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00539	0.0145	CbGeAlD
Disopyramide—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00522	0.0141	CbGeAlD
Disopyramide—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00513	0.0138	CbGeAlD
Disopyramide—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00503	0.0136	CbGeAlD
Disopyramide—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.00494	0.0133	CbGeAlD
Disopyramide—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00475	0.0128	CbGeAlD
Disopyramide—SCN5A—brain—attention deficit hyperactivity disorder	0.00469	0.0126	CbGeAlD
Disopyramide—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00458	0.0123	CbGeAlD
Disopyramide—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00425	0.0115	CbGeAlD
Disopyramide—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.0041	0.011	CbGeAlD
Disopyramide—CHRM2—brain—attention deficit hyperactivity disorder	0.00399	0.0108	CbGeAlD
Disopyramide—SLC22A1—brain—attention deficit hyperactivity disorder	0.00392	0.0106	CbGeAlD
Disopyramide—CHRM1—brain—attention deficit hyperactivity disorder	0.00363	0.0098	CbGeAlD
Disopyramide—CHRM3—brain—attention deficit hyperactivity disorder	0.00325	0.00877	CbGeAlD
Disopyramide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00234	0.0063	CbGeAlD
Disopyramide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00225	0.00607	CbGeAlD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000734	0.00117	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000732	0.00116	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000732	0.00116	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00073	0.00116	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000729	0.00116	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000725	0.00115	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00072	0.00114	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000717	0.00114	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00071	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000703	0.00112	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0007	0.00111	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000692	0.0011	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000691	0.0011	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000684	0.00109	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000683	0.00109	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000683	0.00108	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00068	0.00108	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00068	0.00108	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00068	0.00108	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000678	0.00108	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000674	0.00107	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000671	0.00107	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000662	0.00105	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000661	0.00105	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000659	0.00105	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000653	0.00104	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000653	0.00104	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00065	0.00103	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000648	0.00103	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000642	0.00102	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000641	0.00102	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00064	0.00102	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000636	0.00101	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000635	0.00101	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000634	0.00101	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000629	0.001	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000627	0.000997	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000621	0.000987	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000618	0.000983	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000618	0.000982	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000617	0.00098	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000616	0.000978	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00061	0.000969	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000598	0.00095	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000596	0.000947	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00059	0.000938	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000585	0.00093	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000583	0.000927	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000577	0.000918	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000566	0.0009	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000565	0.000897	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000563	0.000894	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000559	0.000889	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000559	0.000888	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000557	0.000885	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000555	0.000882	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00055	0.000874	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00055	0.000874	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000548	0.000871	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000548	0.000871	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000546	0.000868	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000543	0.000863	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000542	0.000861	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000541	0.00086	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00054	0.000858	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000524	0.000833	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000521	0.000828	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000521	0.000828	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000512	0.000814	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000511	0.000812	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000506	0.000804	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000485	0.00077	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000483	0.000768	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000479	0.000761	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000478	0.000759	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000473	0.000752	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000456	0.000725	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000455	0.000723	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00045	0.000716	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000447	0.00071	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000445	0.000708	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000445	0.000708	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000444	0.000706	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000441	0.000701	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00044	0.000699	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000431	0.000686	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00043	0.000683	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000426	0.000677	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000424	0.000674	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000423	0.000672	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000419	0.000666	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000419	0.000666	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.000665	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000417	0.000663	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000417	0.000663	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000414	0.000658	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000413	0.000657	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000413	0.000657	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000413	0.000656	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000409	0.00065	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000406	0.000645	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000404	0.000643	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000401	0.000637	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00039	0.00062	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000389	0.000618	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000385	0.000612	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000365	0.00058	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000364	0.000578	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00036	0.000572	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000359	0.00057	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000358	0.000568	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000356	0.000565	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000354	0.000563	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.000538	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000332	0.000527	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000328	0.000521	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000316	0.000502	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00031	0.000492	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000309	0.000491	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000306	0.000486	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000292	0.000464	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000285	0.000453	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000284	0.000451	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000281	0.000447	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000281	0.000447	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00028	0.000446	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000279	0.000443	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000278	0.000441	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000277	0.00044	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000275	0.000437	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000273	0.000434	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000272	0.000433	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000271	0.000431	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000271	0.00043	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00027	0.000429	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00027	0.000429	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000267	0.000425	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000253	0.000401	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000252	0.0004	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000251	0.000399	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000248	0.000395	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000246	0.000391	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000245	0.00039	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000245	0.000389	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000244	0.000388	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000244	0.000387	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000243	0.000386	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000243	0.000386	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.000384	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000241	0.000382	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00024	0.000381	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00024	0.000381	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000239	0.00038	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000239	0.00038	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000237	0.000376	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000237	0.000376	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000237	0.000376	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000236	0.000375	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000235	0.000374	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000234	0.000372	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000234	0.000372	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000234	0.000372	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000234	0.000371	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000232	0.000369	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00023	0.000366	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000229	0.000363	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000228	0.000362	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000226	0.000359	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000221	0.000352	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000221	0.000351	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00022	0.00035	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00022	0.000349	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000219	0.000347	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000218	0.000346	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000218	0.000346	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000218	0.000346	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000218	0.000346	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000345	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000215	0.000342	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000215	0.000341	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000214	0.000341	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000214	0.00034	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000214	0.00034	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000212	0.000337	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000201	0.00032	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000201	0.00032	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0002	0.000318	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0002	0.000317	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000199	0.000317	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000198	0.000315	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000198	0.000314	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000187	0.000297	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000184	0.000293	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.000283	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000174	0.000277	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000166	0.000264	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.000264	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000166	0.000263	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000164	0.000261	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000161	0.000256	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000154	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000154	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.000244	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000152	0.000242	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000145	0.000231	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000145	0.00023	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000143	0.000228	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000142	0.000225	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000141	0.000224	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00014	0.000223	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00014	0.000222	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000138	0.00022	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000135	0.000215	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000135	0.000214	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000133	0.000212	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000132	0.00021	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000131	0.000208	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000131	0.000208	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00013	0.000207	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000129	0.000205	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000129	0.000204	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000128	0.000204	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000127	0.000202	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.000202	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000127	0.000201	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000125	0.000199	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000122	0.000194	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000121	0.000193	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000118	0.000188	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000118	0.000187	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000117	0.000186	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.000181	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.28e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.26e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.18e-05	0.00013	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.87e-05	0.000125	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.87e-05	0.000125	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.74e-05	0.000123	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.2e-05	0.000114	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.29e-05	0.0001	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	6.08e-05	9.66e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.99e-05	9.52e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.66e-05	9e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	5.23e-05	8.31e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.77e-05	7.58e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.73e-05	7.53e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.39e-05	6.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.37e-05	6.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.33e-05	6.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.04e-05	3.25e-05	CbGpPWpGaD
